Morgan Stanley Akoya Biosciences, Inc. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 63,766 shares of AKYA stock, worth $137,096. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,766
Previous 86,799
26.54%
Holding current value
$137,096
Previous $423,000
29.31%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AKYA
# of Institutions
70Shares Held
14.9MCall Options Held
71.9KPut Options Held
0-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$10.1 Million20.72% of portfolio
-
Polar Capital Holdings PLC London, X01.58MShares$3.4 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$3.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.35MShares$2.9 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT917KShares$1.97 Million0.58% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $81.5M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...